Document is current
Any future updates will be listed below
-
Authors
Couttas, Timothy A. https://orcid.org/0000-0002-5896-2638
Hoffmann, Anna E.
Jieu, Beverly
Golla, Felix R.
Shepherd, Claire E.
Leweke, F. Markus
Rohleder, Cathrin https://orcid.org/0000-0002-3559-1846
-
Funding
Funding for this research was provided by:
Moyira Elizabeth Vine Fund, Australia Deputy Vice Chancellor-Start Up Funds, University of Sydney
Australian Government Research Training Program (RTP) Scholarship
Deutscher Akademischer Austauschdienst (Programme to increase the Mobility of Students from Germany (PROMOS))
Bundesministerium für Bildung und Forschung (Germany Scholarship)
- License Information
-
More Information
Article History
Received: 21 August 2025
Revised: 16 April 2026
Accepted: 13 May 2026
First Online: 28 May 2026
Competing interests
: The authors declare the following financial interests/personal relationships: FML is a shareholder of curantis UG (Ltd.). CR is a shareholder of lero bioscience UG (Ltd.). CR, FRG, AEH, and FML report financial support as full- or part-time employees of Endosane® Pharmaceuticals GmbH. FML received an Investigator Initiated Trial Grant from Endosane® Pharmaceuticals GmbH. The remaining authors have nothing to disclose.
: Ethic Statement is not applicable to this manuscript as no new human data were created or analysed in this study.
